Not applicableWithdrawnNCT01300299What this trial is testingSTEREOtactic Radiation and Chemotherapy in Lung Cancer (STEREO)Who this might be right forNon-small Cell Lung Cancer (NSCLC) University of Louisville
Testing effectiveness (Phase 2)Study completedNCT00092001What this trial is testingStudy Of SU011248 In Patients With Metastatic Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Pfizer 111
Testing effectiveness (Phase 2)UnknownNCT06182800What this trial is testingAdebrelimab Combined With Bevacizumab and Docetaxel for Advanced Non-Squamous Non-small Cell Lung Cancer After Progression on First-line ImmunotherapyWho this might be right forNon-small Cell Lung Cancer The First Affiliated Hospital of Xinxiang Medical College 35
Testing effectiveness (Phase 2)Study completedNCT05253807What this trial is testingStudy to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR AlterationWho this might be right forNon-Small Cell Lung Cancer (NSCLC) Incyte Corporation 8
Testing effectiveness (Phase 2)Study completedNCT00368992What this trial is testingS0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung CancerWho this might be right forAdenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+5 more National Cancer Institute (NCI) 110
Large-scale testing (Phase 3)Study completedNCT00982111What this trial is testingFirst-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-CisplatinWho this might be right forNon Small Cell Lung Cancer Eli Lilly and Company 633
Not applicableStudy completedNCT03725475What this trial is testingReveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer PatientsWho this might be right forNon-small-cell Lung Cancer (NSCLC) AstraZeneca 3,111
Testing effectiveness (Phase 2)Study completedNCT00988936What this trial is testingEfficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic DrugWho this might be right forMetastatic Breast CancerMetastatic Colon/Rectum CancerNon-squamous Non-small Cell Lung Cancer Siemens Molecular Imaging 35
Testing effectiveness (Phase 2)Study completedNCT01533181What this trial is testingLinsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung CancerWho this might be right forRecurrent Small Cell Lung Carcinoma National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Looking for participantsNCT05498428What this trial is testingAmivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-small-Cell Lung Janssen Research & Development, LLC 520
Testing effectiveness (Phase 2)Ended earlyNCT02335944What this trial is testingStudy of Safety and Efficacy of EGFR-TKI EGF816 in Combination With cMET Inhibitor INC280 in Adult Patients With EGFR Mutated Non Small Cell Lung Cancer.Who this might be right forNon Small Cell Lung Cancer Novartis Pharmaceuticals 177
Large-scale testing (Phase 3)Study completedNCT01631357What this trial is testingStudy of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung CancerWho this might be right forNon-small Cell Lung CancerSquamous Cell Carcinoma Tianjin Medical University Cancer Institute and Hospital 96
Not applicableUnknownNCT04553601What this trial is testingMolecular Imaging Visualization of Tumor Heterogeneity in Non-small Cell Lung CancerWho this might be right forNSCLCPET/CTBiopsy+3 more The First Affiliated Hospital of Xiamen University 150
Early research (Phase 1)Not Yet RecruitingNCT07650357What this trial is testingCLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)Who this might be right forAdvanced Solid TumorNon Small Cell Lung CancerPancreatic Carcinoma+1 more Clasp Therapeutics, Inc. 140
Testing effectiveness (Phase 2)UnknownNCT05668767What this trial is testingSurufatinib in Combination of Durvalumab and EP/EC in the Firstly-line Treatment of ES-SCLCWho this might be right forExtensive-stage Small-cell Lung Cancer Beijing Chest Hospital 20
Large-scale testing (Phase 3)Study completedNCT03856411What this trial is testingEvaluate the Efficacy and Safety of Toripalimab or Placebo Combined With Chemotherapy in Treatment-naive Advanced NSCLCWho this might be right forTreatment-naive Advanced Non-small Cell Lung Cancer Shanghai Junshi Bioscience Co., Ltd. 465
Large-scale testing (Phase 3)Looking for participantsNCT06754644What this trial is testingEvaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLCWho this might be right forNSCLC Qilu Pharmaceutical Co., Ltd. 808
Testing effectiveness (Phase 2)WithdrawnNCT02662634What this trial is testingA Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer (NSCLC) GU Research Network, LLC
Testing effectiveness (Phase 2)Study completedNCT00367679What this trial is testingPazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung CancerLung Cancer, Non-Small Cell GlaxoSmithKline 35
Large-scale testing (Phase 3)Looking for participantsNCT06598527What this trial is testingStereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumab Plus Platinum-based Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer: A Phase Ⅲ, Randomized, Multicenter, Prospective StudyWho this might be right forLung Cancer (NSCLC) Yang Hong 360